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Abstract
Background: The aim of the present study was to investigate the incidence of adverse events (AEs) during intra-hospital
transport (IHT) of critically ill patients and evaluate the risk factors associated with these events.
Methods: This prospective multicenter observational study was performed in 34 intensive care units in China during
20 consecutive days from 5 November to 25 November 2012. All consecutive patients who required IHT for diagnostic
testing or therapeutic procedures during the study period were included. All AEs that occurred during IHT
were recorded. The incidence of AEs was defined as the rate of transports with at least one AE. The statistical
analysis included a description of demographic and clinical characteristics of the cohort as well as identification of risk
factors for AEs during IHT by univariate and multivariate logistic regression analyses.
Results: In total, 441 IHTs of 369 critically ill patients were analyzed. The overall incidence of AEs was 79.8 % (352 IHTs).
The proportion of equipment- and staff-related adverse events was 7.9 % (35 IHTs). The rate of patient-related adverse
events (P-AEs) was 79.4 % (349 IHTs). The rates of vital sign–related P-AEs and arterial blood gas analysis–related P-AEs
were 57.1 % (252 IHTs) and 46.9 % (207 IHTs), respectively. The incidence of critical P-AEs was 33.1 % (146 IHTs). The
rates of vital sign–related critical P-AEs and arterial blood gas analysis–related critical P-AEs were 22.9 % (101 IHTs) and
15.0 % (66 IHTs), respectively. All data collected in our study were considered potential risk factors. In the multivariate
analysis, predictive factors for P-AEs were pH, partial pressure of carbon dioxide in arterial blood, lactate level, glucose
level, and heart rate before IHT. Furthermore, the Acute Physiology and Chronic Health Evaluation II score, partial
pressure of oxygen in arterial blood, lactate level, glucose level, heart rate, respiratory rate, pulse oximetry, and sedation
before transport were independent influential factors for critical P-AEs during IHT.
Conclusions: The incidence of P-AEs during IHT of critically ill patients was high. Risk factors for P-AEs during IHT were
identified. Strategies are needed to reduce their frequency.
Trial registration: Chinese Clinical Trial Register identifier ChiCTR-OCS-12002661. Registered 5 November 2012.
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Background
Intra-hospital transport (IHT) is an inevitable and im-
portant part of intensive care unit (ICU) care. IHT is fre-
quently required to perform diagnostic or therapeutic
procedures for critically ill patients. Transported patients
have more significant illnesses than patients not requiring
transport [1]. Additionally, adverse events (AEs) during
IHT occur commonly, and transported patients have
significantly higher risks than non-transported patients in
the ICU [1–3]. The decision to transport a critically ill pa-
tient is based on an assessment of the potential benefits
and risks [4]. Knowledge of the incidence of AEs and risk
factors for AEs during IHT is essential for scheduling safe
ICU patient transport.
The overall incidence of AEs during IHT of critically
ill patients reportedly ranges from 1.7 % to 75.7 % [5, 6].
Several explanations have been proposed for this wide
range. One explanation is the different types of patients
studied. Patients studied include those in the medical
ICU [3], surgical ICU [7], anesthesiological ICU [6],
neurological ICU [8], and emergency department [9–11];
mechanically ventilated patients [2, 3, 12]; and patients
going to different transport destinations. Another explan-
ation is the different definitions of AEs used among vari-
ous reports. The most commonly used AE classifications
are equipment/staff- and patient-related adverse events
(P-AE) [12–14]. However, there is no standard definition
of respiratory or circulatory AEs. A third explanation for
the wide range of AEs during IHT is the different time pe-
riods studied. AEs related to IHT can occur during trans-
port or secondarily even on the following day. Finally, the
wide range may be explained by different programs used
to limit AEs. This includes the use of specialized transport
teams during IHT [5] or the use of designed transport
checklists by acting nurses before the patients are trans-
ported [10].
To our knowledge, this is the first multicenter obser-
vational study to comprehensively identify the incidence
and risk factors of AEs during the IHT of different ICU
patients. These findings will help train a cadre of IHT
personnel to perform safer ICU patient transport.
Methods
Study design and patients
A prospective multicenter observational study was car-
ried out in 34 closed ICUs (with staff members formally
trained in critical care) in China during 20 consecutive
days from 5 November to 25 November 2012 (Fig. 1).
All consecutive patients who required IHT for diagnostic
testing or therapeutic procedures during the study
period were included. The study design and informed
consent form were both approved by the medical ethics
committee of the Second Affiliated Hospital of Harbin
Medical University (the organizer institution). The study
was registered in the Chinese Clinical Trial Register as
ChiCTR-OCS-12002661.
No specific protocol, including special staff training,
was used to manage critically ill patients before or
during IHT. The risk or benefit of IHT for critically ill
patients was assessed by the in-charge ICU physician.
Patients who were transported to the operating room or
the general ward after diagnostic testing were excluded.
Written informed consent was obtained from the patients
or their guardians or family members.
Data collection and outcome measures
Each participating ICU had a written procedure for data
collection. All data were collected by trained observers
from each participating ICU using a case report form.
The observation period was divided into three parts:
pre-IHT, IHT, and post-IHT. The pre-IHT period was
defined as the time before the patient departed for IHT,
and the post-IHT period was defined as the time after
the patient returned to their ICU bed. Each period
was measured with a maximum error of 5 minutes. All
data in the pre-IHT period was established as baseline
information.
Patient characteristics were collected immediately after
the patient was enrolled in the study. The severity of
illness was determined using Acute Physiology and
Chronic Health Evaluation (APACHE) II scores obtained
on the day of transport. The Glasgow Coma Scale (GCS)
score was evaluated on the basis of the patient’s last condi-
tion before transport if the patient had been sedated. IHT
characteristics such as the transport destination were also
recorded. Arterial blood gas analysis findings [pH, partial
pressure of oxygen in arterial blood (PaO2), partial pres-
sure of carbon dioxide in arterial blood (PaCO2), bicar-
bonate, lactate level, and glucose level] were reviewed
during the pre-IHT and post-IHT periods. Transport
monitors were used to collect vital signs [systolic blood
pressure, diastolic blood pressure, mean arterial pressure,
heart rate (HR), respiratory rate (RR), and pulse oximetry
(SpO2)] every 5 minutes during the entire observation
period. The vital signs and arterial blood gas analysis
findings were categorized according to severity [15–17]
(Fig. 2).
All AEs that occurred during IHT were recorded, re-
gardless of whether a treatment was performed. AEs
were classified as equipment- and staff-related adverse
events (E-AEs) or as P-AEs. A P-AE was defined as any
event that affected patient stability. A vital sign–related
or arterial blood gas analysis–related P-AE was defined
as an AE associated with detection of abnormal or more
severe monitored parameters during the IHT period and
the post-IHT period. A critical P-AE was defined as a
vital sign or arterial blood gas analysis parameter with
more severe abnormality detected (category 2 or worse),
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as well as other life-threatening events such as airway
obstruction, accidental extubation, cardiac arrest, malig-
nant arrhythmias, and others. Different AEs might occur
during one transport. The incidence of AEs was defined
as the rate of transports with at least one AE.
Data analysis
The sample size was calculated using the formula
n = z2α/2π(1 − π)/δ
2 (where α = 0.05, zα/2 = 1.96, π = 50 %,
and δ = 5 %). Because the known incidence of AEs from
previous studies of ICU patients during transport varies
from 1.7 % to 75.7 %, we calculated the sample size
as 384 IHTs with the assumption that 50 % of patients
would experience an AE. We anticipated that 10 % of
the data would be missing, which increased the target
IHT sample size to 422.
Statistical analysis was performed using SAS software
(release 9.13, serial 989155; SAS Institute, Cary, NC, USA).
Quantitative variables are reported as mean with standard
deviation or as median with 25th and 75th percentiles.
Qualitative data are described as values or percentages.
A P value <0.05 was considered statistically significant.
Possible risk factors for P-AEs during IHT were identi-
fied first by univariate logistic regression analysis. Those
with a significance level <0.05 were included in a step-
wise multivariate logistic regression analysis. Results are




In total, 376 critically ill patients were enrolled during
the study period (Fig. 3). These patients underwent 448
IHTs. Seven IHTs were excluded because of a lack of
data documentation (n = 2) or a patient age <18 years
(n = 5). Thus, 369 critically ill patients with 441 IHTs
were included in the analysis. Fifty-six patients under-
went more than 1 IHT, including 42 with 2 IHTs, 12
with 3 IHTs, and 2 with 4 IHTs. Thus, 72 IHTs were
not the first IHT for that patient during that ICU
stay. Patient and clinical characteristics before IHT
were determined (Tables 1 and 2).
Patient IHT characteristics were evaluated (Table 3). In
total, 433 IHTs (98.2 %) were to only one location, most
commonly for computed tomographic imaging (380 IHTs,
86.2 %). Other destinations included ultrasonography
(18 IHTs, 4.1 %), radiation treatment (8 IHTs, 1.8 %),
magnetic resonance imaging (7 IHTs, 1.6 %), endoscopy
(4 IHTs, 0.9 %), and angiography (4 IHTs, 0.9 %). Only
eight IHTs (1.8 %) were to more than one location.
Fig. 2 Severity categories of vital signs and arterial blood gas analysis.
SBP systolic blood pressure, SpO2 pulse oximetry, PaO2 partial pressure
of oxygen in arterial blood, PaCO2 partial pressure of carbon dioxide in
arterial blood, HCO3
− bicarbonate level
Fig. 1 Thirty-four clinical centers in China participated in this study. Numbers represent number of centers at each location
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Eighty-three IHTs (18.8 %) were emergent. The majority
of IHTs (438 IHTs, 99.3 %) were carried out successfully.
Three patients were not transferred successfully, owing to
serious AEs (airway obstruction, accidental extubation,
and a low SpO2 of 60 %, respectively). A minority of IHTs
were performed between 5:00 PM and 8 AM (27 IHTs,
6.1 %). The median duration of IHT was 25 minutes
(25th–75th percentile range 20–35 minutes).
AEs during IHT
Table 4 shows the incidence and types of AEs during
IHT. The overall incidence of AEs was 79.8 % (352
IHTs). The proportion of E-AEs was 7.9 % (35 IHTs).
Most of these involved a disconnected monitor power
source or monitor power failure (11 IHTs, 2.5 %),
disconnected or depleted oxygen supply (9 IHTs, 2.0 %),
or unexpected delays during transport (8 IHTs, 1.8 %).
The rate of P-AEs was 79.4 % (349 IHTs). The rates of
vital sign–related P-AEs and arterial blood gas analysis–
related P-AEs were 57.1 % (252 IHTs) and 46.9 % (207
IHTs), respectively. Other P-AEs comprised mainly anx-
iety (66 IHTs, 15.0 %), agitation (49 IHTs, 11.1 %), resist-
ance to ventilation when intubated (54 IHTs, 12.2 %),
and pain or discomfort (27 IHTs, 6.1 %). The incidence
of critical P-AEs was 33.1 % (146 IHTs) (Table 5). The
rates of vital sign–related and arterial blood gas ana-
lysis–related critical P-AEs were 22.9 % (101 IHTs) and
15.0 % (66 IHTs), respectively. The majority of these
AEs involved RR abnormality or more severe (54 IHTs,
12.2 %), HR abnormality or more severe (31 IHTs, 7.0 %),
PaO2 abnormality or more severe (30 IHTs, 6.8 %), and
lactate level abnormality or more severe (28 IHTs, 6.4 %).
One accidental extubation and one airway obstruction
occurred. No patient experienced cardiac arrest during
the study period.
When a vital sign–related P-AE was defined as an AE
associated with detection of abnormal or more severe
monitored parameters only in the post-IHT period, the
rates of vital sign–related P-AEs and critical P-AEs were
29.5 % (130 IHTs) and 11.8 % (52 IHTs), respectively.
Risk factors for P-AEs during IHT
Univariate and stepwise multivariate logistic regression
analyses were performed to identify factors present before
or during IHT that were related to an increase in P-AEs
in critically ill patients during transport. Comparisons
were made between reference category and each of the
remaining groups per characteristic.
Table 6 shows the risk factors for P-AEs during IHT.
Patient characteristics did not significantly affect the
occurrence of P-AEs during transport. Univariate logistic
Fig. 3 Patients undergoing intra-hospital (IHT) transport
Table 1 Patient characteristics (N = 441 intra-hospital transports evaluated)
Patient characteristic Median [25th–75th percentile] Mean ± SD Transports (n) Transports (%)










APACHE II score 14 [9–21] 15.4 ± 8.1
GCS score 15 [9–15] 11.9 ± 4.2
APACHE Acute Physiology and Chronic Health Evaluation, GCS Glasgow Coma Scale, ICU intensive care unit SD standard deviation
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regression analysis showed that the APACHE II score
and vasoactive drug support before transport were asso-
ciated with P-AEs during IHT. More specifically, pa-
tients with an APACHE II score ≥20 had a significantly
higher incidence of P-AEs than did those with an APA-
CHE II score ≤11 (P = 0.02). More P-AEs occurred in
patients with a pH, PaCO2, lactate level, glucose level,
HR, and RR in severity category 1 or 2 than in severity
category 0 (P < 0.05). However, after adjusting for poten-
tial confounding factors through the multivariate ana-
lysis, only pH, PaCO2, lactate level, glucose level, and
Table 2 Clinical characteristics before IHT (N = 441 intra-hospital
transports evaluated)
Clinical characteristic Transports (n) Transports (%)




No ventilatory support 237 53.7
Nasal catheter 155 35.1
Face mask 82 18.6
Ventilatory support 204 46.3
Non-invasive ventilation 8 1.8
Invasive ventilation 196 44.4
Catheter use
Central venous 317 71.9
Peripheral vein 171 38.8
Arterial 107 24.3
Nasogastric tube 291 66.0
Foley catheter 311 70.5
Drainage catheter 138 31.3
Other 22 5.0














Severity categories of vital signsb
Respiratory rate
Category 0 346 78.5
Category 1 48 10.9
Category 2 47 10.7
Heart rate
Category 0 355 80.5
Category 1 65 14.7
Category 2 21 4.8
Systolic blood pressure
Category 0 381 86.4
Table 2 Clinical characteristics before IHT (N = 441 intra-hospital
transports evaluated) (Continued)
Category 1 51 11.6
Category 2 9 2.0
SpO2
Category 0 391 88.7
Category 1 47 10.7
Category 2 3 0.7
Severity categories of ABGb
pH
Category 0 253 57.4
Category 1 186 42.2
Category 2 2 0.5
PaO2
Category 0 326 73.9
Category 1 95 21.5
Category 2 20 4.5
PaCO2
Category 0 197 44.7
Category 1 218 49.4
Category 2 26 5.9
Bicarbonate level
Category 0 220 49.9
Category 1 217 49.2
Category 2 4 0.9
Lactate level
Category 0 345 78.2
Category 1 72 16.3
Category 2 24 5.4
Glucose level
Category 0 333 75.5
Category 1 101 22.9
Category 2 7 1.6
SBP systolic blood pressure, SpO2 pulse oximetry, ABG arterial blood gas,
PaO2 partial pressure of oxygen in arterial blood, PaCO2 partial pressure of
carbon dioxide in arterial blood
aMedications were delivered as continuous infusions
bSeverity categories defined in Fig. 2
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HR were independent influential factors for P-AEs during
IHT (P < 0.05). Significantly more P-AEs occurred in
patients with these parameters in severity category 1
or 2 than in severity category 0 (P < 0.05). Ventilation and
transport characteristics were not associated with P-AEs
during IHT. There was no evidence that patients receiving
analgesia or sedation had more P-AEs during transport.
Risk factors for critical P-AEs during IHT are shown
in Table 7. Univariate logistic regression analysis identi-
fied pre-IHT parameters or transport characteristics
associated with P-AEs during IHT (P < 0.05), namely
weight, APACHE II score, GCS score, number of cathe-
ters, PaO2, lactate level, glucose level, HR, RR, SpO2,
sedation before transport, vasoactive drug support dur-
ing transport, and emergency transport. In the multivari-
ate logistic regression analysis, APACHE II score, PaO2,
lactate level, glucose level, HR, RR, SpO2, and sedation
before transport were independent influential factors for
critical P-AEs during IHT (P < 0.05). Furthermore, pa-
tients with an APACHE II score ≥20 had a significantly
higher incidence of critical P-AEs than did patients with
an APACHE II score ≤11 (P = 0.01). A significantly
higher rate of critical P-AEs occurred in patients with a
parameter pre-IHT (PaO2, lactate level, glucose level,
HR, RR, and SpO2) in severity category 1 or 2 than in se-
verity category 0 (P < 0.05). Ventilation, night transport,
multiple IHTs of one patient, and transport duration were
not associated with critical P-AEs during IHT.
Discussion
To our knowledge, this is the first prospective multicenter
study of the incidence and risk factors for AEs during
IHT in both medical and surgical ICU patients, including
Table 3 Intra-hospital transport characteristics (N = 441 intra-
hospital transports evaluated)
IHT characteristic Transports (n) Transports (%)
Transport destination
Computed tomography 380 86.2
Ultrasonography 18 4.1
Radiation therapy 8 1.8
Magnetic resonance imaging 7 1.6
Digestive endoscopy 4 0.9
Angiography 4 0.9
Other 12 2.7




Multiple IHTs of one patient 72 16.3
Transport time
Daytime (8:00 AM–5:00 PM) 414 93.9
Nighttime (5:00 PM–8:00 AM) 27 6.1
Medications administered during IHTa
Analgesia 45 10.2
Sedation 80 18.1
Vasoactive drug support 92 20.7
Completed transports 438 99.3
IHT intra-hospital transport
aMedications were delivered as continuous infusion






Total AEs 352 79.8
Equipment- or staff-related AEs 35 7.9
Loss of monitor power 11 2.5
Vascular tubing obstructed 4 0.9
Disconnected or depleted of oxygen supply 9 2.0
Loss of ventilator power 3 0.7
Unexpected delay ≥15 minutes 8 1.8
Other 4 0.9
Patient-related AEs (P-AEs) 349 79.4
Vital sign–related P-AEsb 252 57.1
RR abnormality or more severe 99 22.5
HR abnormality or more severe 69 15.7
SBP abnormality or more severe 78 17.7
SpO2 abnormality or more severe 102 23.1
Arterial blood gas analysis–related P-AEsb 207 46.9
pH abnormality or more severe 53 12.0
PaO2 abnormality or more severe 70 15.9
PaCO2 abnormality or more severe 63 14.3
HCO3
− abnormality or more severe 36 8.2
Lactate level abnormality or more severe 42 9.5
Glucose level abnormality or more severe 39 8.8
New-onset arrhythmia 3 0.7
Anxiety 66 15.0
Agitation 49 11.1
Pain or discomfort 27 6.1
Resistance to ventilation when intubated 54 12.2
Accidental extubation 1 0.2
Nausea or vomiting 2 0.5
Airway obstruction 1 0.2
Other 2 0.5
AE adverse event, RR respiratory rate, HR heart rate, SBP systolic blood pressure,
SpO2 pulse oximetry, PaO2 partial pressure of oxygen in arterial blood,
PaCO2 partial pressure of carbon dioxide in arterial blood, HCO3
− bicarbonate level
aNumber of transports with at least one AE
bDefined as an AE associated with detection of abnormal or more severe
monitored parameters during the intra-hospital transport (IHT) period and
post-IHT period
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both mechanically ventilated and non-ventilated patients.
Three previous reports of IHT of ICU patients contained
more transports than our study. One observational study
was carried out in a cohort of 452 IHTs of 226 adults and
infants from 3 anesthesiology ICUs in Austria [6]. In total,
4.2 % of IHTs were associated with a critical incident. Kue
et al. [5] reported an AE rate of 1.7 % in a retrospective
study of 3358 IHTs by a specialized transport team in the
United States. AEs included hypoxia and alterations in
blood pressure. Furthermore, a multicenter cohort of 1782
mechanically ventilated adult ICU patients with 3006 IHTs
experienced 621 AEs (37.4 %). The authors of that study
compared 1659 transported patients with 3344 patients
who were not transported [2]. Pneumothorax, atelectasis,
ventilator-associated pneumonia, hypoglycemia, hypergly-
cemia, and hypernatremia were reported as complications
that occurred more frequently in the transported popula-
tion. A longer ICU stay, but not a higher mortality rate,
was found in transported patients than in non-transported
patients. No risk factors for AEs were reported. Perhaps an
approach integrating multiple vital signs derangements in
one score, such as the Modified Early Warning Score,
might be helpful as a predictor. Additionally, AEs have
been reported in many studies with more critically ill
patients during inter-hospital transport [18–23] than
we included in our study, but few data have documented
the risks [24–26]. Although these findings were derived
from studies on inter-hospital transport, they may also
apply to IHT [20].
Definition of AEs during IHT
Reported rates of transfer-related AEs vary among different
studies, not only because of differences in incidences but
also because different definitions were used [22]. How to
more reasonably define vital sign–related or laboratory
work–related AEs is unclear. First, conditions of critically
ill patients are prone to change even without transport. It
is difficult to tell if these changes would have occurred if
the patients had remained where they were. Second, no
definition perfectly distinguishes whether such changes are
actually adverse or simply represent physiologic variability
among patients. Third, sicker patients are more likely
to deteriorate during transfer [23]. Therefore, even a
minimal change in vital signs or laboratory work might be
clinically important.
Vital signs and arterial blood gas analysis findings were
classified according to their severity in our study, and
changes in severity categories were used to define vital
sign–related and arterial blood gas analysis–related P-AEs.
However, not all of the above-mentioned problems can be
solved by this definition. We believe that a consensus on
the definition of transfer-related AEs must be reached in
the future to allow for appropriate comparison of AE rates.
Incidence of AE
In this study, we evaluated 369 adult critically ill patients
with 441 IHTs. The overall incidence of AEs was 79.8 %,
and 33.1 % of IHTs were associated with a critical P-AE.
These findings are similar to those in some previous
reports [9, 12–14] but greater than those in the largest
studies evaluating IHT of ICU patients. These results
are noteworthy, such that physicians should pay greater
attention to the safety of critically ill patients during IHT.
A greater number of clinical characteristics were
assessed in our study than in previous reports. The high
AE rate found in our study is attributable to the defin-
ition of P-AE. First, vital signs were monitored and
noted every 5 minutes during transport; thus, more tran-
sient events might have been captured than in previous
studies [2]. In total, 57.1 % of the IHTs were associated
with vital sign–related P-AEs, and 22.9 % of the IHTs
were associated with vital sign–related critical P-AEs.
However, if changes in these variables during the IHT
period were not detected (vital signs were observed or
collected just before and after transport, like in most
previous studies), the rates of vital sign–related P-AEs
and critical P-AEs were 29.5 % and 11.8 %, respectively.
More than half of the vital sign–related P-AEs might not
have been identified. Second, the careful observation of
arterial blood gas values before and after IHT may also
Table 5 Critical patient-related adverse events during intra-hospital
transports (N= 441 intra-hospital transports evaluated)




Total critical P-AEs 146 33.1
Vital sign–related critical P-AEsb 101 22.9
RR abnormality or more severe 54 12.2
HR abnormality or more severe 31 7.0
SBP abnormality or more severe 21 4.7
SpO2 abnormality or more severe 11 2.5
Arterial blood gas analysis–related critical P-AEsb 66 15.0
pH abnormality or more severe 2 0.5
PaO2 abnormality or more severe 30 6.8
PaCO2 abnormality or more severe 7 1.6
HCO3
− abnormality or more severe 3 0.7
Lactate level abnormality or more severe 28 6.4
Glucose level abnormality or more severe 6 1.4
Accidental extubation 1 0.2
Airway obstruction 1 0.2
P-AE patient-related adverse events, RR respiratory rate, HR heart rate, SBP systolic
blood pressure, SpO2 pulse oximetry, PaO2 partial pressure of oxygen in arterial
blood, PaCO2 partial pressure of carbon dioxide in arterial blood,
HCO3
− bicarbonate level
aNumber of transports with at least one AE
bDefined as a parameter with more severe abnormality detected (category 2
or worse in Fig. 2)
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Table 6 Risk factors for patient-related adverse events during intra-hospital transport
Variable Univariate analysis Multivariate analysis
OR (95 % CI) P value OR (95 % CI) P value
Patient characteristics
Age, yr 1.00 (0.99–1.02) 0.67 NT
Sex 0.94 (0.58–1.51) 0.79 NT
Weight, kg 1.02 (1.00–1.04) 0.06 NT
< 65 Reference –
≥ 65 1.46 (0.92–2.32) 0.11
ICU admission type 1.04 (0.80–1.34) 0.79 NT
Clinical characteristics before transport
APACHE II score 1.43 (1.06–1.91) 0.02*
≤ 11 Reference – Reference –
12–19 1.25 (0.74–2.12) 0.40 1.27 (0.73–2.22) 0.40
≥ 20 2.11 (1.14–3.88) 0.02* 1.89 (0.98–3.67) 0.06
Glasgow Coma Scale score 1.14 (0.86–1.51) 0.36 NT
15 Reference –
9–14 0.86 (0.47–1.56) 0.62
≤ 8 1.39 (0.77–2.51) 0.27
Artificial airway 1.26 (0.80–2.01) 0.32 NT
Ventilation 1.22 (0.77–1.94) 0.40 NT
Number of catheters 1.24 (1.00–1.54) 0.05 NT
Arterial blood gas analysis
pH
7.35–7.45 Reference – Reference –
< 7.35 or >7.45 1.55 (1.34–1.88) 0.01* 1.53 (1.32–1.88) 0.01*
PaO2 1.00 (0.99–1.00) 0.07 NT
PaCO2, mmHg
35–45 Reference –
< 35 or >45 1.61 (1.38–1.97) 0.04* 1.49 (1.29–1.81) 0.00*
Bicarbonate level, mmol/L NT
22–27 Reference –
< 22 or >27 1.08 (0.68–1.71) 0.75
Lactate level, mmol/L 1.60 (1.17–2.18) 0.00*
< 2 reference – Reference –
≥ 2 2.11 (1.10–4.07) 0.03* 1.47 (1.04–2.08) 0.03*
Glucose level, mmol/L
4.0–10.0 Reference –




< 90 or >150 1.37 (0.67–2.82) 0.39
DBP, mmHg 1.01 (1.00–1.03) 0.12 NT
MAP, mmHg 1.02 (1.00–1.03) 0.08 NT
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have contributed to the high AE rate, assessed in few pre-
vious studies [12, 27]. The incidence of arterial blood gas
analysis–related P-AEs was unexpectedly high (46.9 % of
IHTs). Additionally, AEs during IHT related to lactate
(42 IHTs, 9.5 %) and bicarbonate (36 IHTs, 8.2 %) levels
have not been reported previously. Patient glucose levels
during IHT were described in only one recent report
[2]. The rates of hypoglycemia and hyperglycemia in
this study were 3.38 % and 23.75 %, respectively. The
percentage of glucose level deterioration was 8.8 %
(39 IHTs) in our study, and a low rate of critical glucose
level deterioration was found in our patients (6 IHTs,
1.4 %). These occurrences may be secondary to in-
terruptions in nutrition support or insulin therapy
during transport.
Identification of E-AEs is important because such
AEs can lead to P-AEs. The incidence of E-AEs in
the present study (35 IHTs, 7.9 %) was lower than
rates reported in previous studies (11–34 %) [13, 28].
Most E-AEs were related to a disconnected power source
or power failure of a monitor, a disconnected or depleted
oxygen supply, or unexpected delays. These AEs were
associated with insufficient preparation before IHT that
did not take into account potential risk factors. Careful
preparation of equipment before transport and assistance
by well-trained personnel during IHT should minimize
these problems.
Risk factors for P-AEs
Accurate assessment of the risk/benefit ratio of each
transport is the key to reducing AEs during IHT of
critically ill patients. Physicians should consider both the
indications for and risk factors associated with IHT.
Adult ICU assessment models of illness severity have
been used to predict patient outcomes for three decades
[29, 30]. Several researchers have evaluated the predict-
ive value of AEs during transport of critically ill patients.
The Therapeutic Intervention Scoring System score is
reportedly associated with the occurrence of AEs during
transport [31]. The Simplified Acute Physiology Score II
and Sequential Organ Failure Assessment score have not
been reported to predict AEs during transport [3, 25].
Disease severity as assessed by APACHE II scores was
correlated with a higher risk of physiologic deterioration
[6]. In the present study, the APACHE II score on the
day of IHT was not an independent influential factor for
P-AEs during IHT, but patients with an APACHE II
score ≥20 had a significantly higher incidence of critical
P-AEs than did patients with an APACHE II score ≤11.
Further work is needed to evaluate the use of illness
severity scores in predicting AEs during IHT.
The use of artificial airways was not associated with
P-AEs during IHT by logistic regression analysis. Venti-
lated patients experience physical discomfort, anxiety, and
hemodynamic instability and might be at higher risk for
Table 6 Risk factors for patient-related adverse events during intra-hospital transport (Continued)
Heart rate
50–110 Reference – Reference –
< 50 or >110 3.02 (1.40–6.51) 0.00* 2.73 (1.21–6.16) 0.02*
Respiratory rate
12–25 Reference – Reference –
< 12 or >25 2.33 (1.19–4.59) 0.01* 2.00 (0.98–4.10) 0.06
Pulse oximetry 0.93 (0.85–1.02) 0.13 NT
Analgesia 1.60 (0.78–3.27) 0.20 NT
Sedation 1.42 (0.80–2.54) 0.24 NT
Vasoactive drug support 2.02 (1.09–3.75) 0.03* 1.85 (0.97–3.55) 0.06
Transport characteristics
Analgesia 1.25 (0.56–2.78) 0.59 NT
Sedation 1.07 (0.58–1.95) 0.83 NT
Vasoactive drug support 1.60 (0.86–2.99) 0.14 NT
Emergency transport 0.52 (0.26–1.03) 0.06 NT
Multiple IHTs of one patient 1.29 (0.76–2.18) 0.34 NT
Night transport 0.64 (0.22–1.91) 0.43 NT
Transport duration, minutes 1.01 (0.99–1.03) 0.32 NT
APACHE Acute Physiology and Chronic Health Evaluation, PaO2 partial pressure of oxygen in arterial blood, PaCO2 partial pressure of carbon dioxide in arterial blood,
SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, NT not tested, OR odds ratio, CI confidence interval
*P < 0.05
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Table 7 Risk factors for critical patient-related adverse events during intra-hospital transport
Variable Univariate analysis Multivariate analysis
OR (95 % CI) P value OR (95 % CI) P value
Patient characteristics
Age, yr 1.00 (0.99–1.01) 0.71 NT
Sex 0.70 (0.46–1.08) 0.10 NT
Weight, kg 1.03 (1.01–1.04) 0.00*
< 65 Reference – Reference –
≥ 65 1.95 (1.30–2.94) 0.00* 1.55 (0.95–2.54) 0.08
ICU admission type 0.95 (0.76–1.19) 0.67 NT
Clinical characteristics before transport
APACHE II score 1.66 (1.29–2.14) 0.00*
≤ 11 Reference – Reference –
12–19 1.66 (1.01–2.74) 0.04* 1.44 (0.79–2.63) 0.23
≥ 20 2.75 (1.66–4.57) 0.00* 2.49 (1.23–5.03) 0.01*
Glasgow Coma Scale score 0.76 (0.60–0.96) 0.02*
15 Reference – Reference –
9–14 0.93 (0.53–1.64) 0.80 0.67 (0.33–1.38) 0.28
≤ 8 1.82 (1.14–2.91) 0.01* 0.89 (0.46–1.74) 0.74
Artificial airway 1.38 (0.92–2.07) 0.12 NT
Ventilation 1.48 (0.99–2.20) 0.06 NT
Number of catheter 1.28 (1.07–1.54) 0.01* 1.20 (0.95–1.51) 0.13
Arterial blood gas analysis
pH NT
7.35–7.45 Reference –
< 7.35 or >7.45 1.03 (0.69–1.54) 0.88
PaO2, mmHg 0.99 (0.99–1.00) 0.00*
≥ 80 Reference – Reference –
< 80 2.49 (1.61–3.86) 0.00* 2.26 (1.31–3.91) 0.00*
PaCO2, mmHg NT
35–45 Reference –
< 35 or >45 1.36 (0.91–2.02) 0.13
Bicarbonate level, mmol/L NT
22–27 Reference –
< 22 or >27 1.28 (0.86–1.92) 0.23
Lactate level, mmol/L 1.87 (1.51–2.33) 0.00*
< 2 Reference –
≥ 2 2.82 (1.77–4.49) 0.00* 3.12 (1.75–5.58) 0.00*
Glucose level, mmol/L
4.0–10.0 Reference –




< 90 or >150 1.10 (0.62–1.95) 0.74
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P-AEs during transport. However, our study showed that
mechanical ventilation was not a risk factor for P-AEs
during IHT, in contrast to previous reports [6, 26]. This
result may be because of the lower incidence of E-AEs
in our study or because ventilation settings were not
analyzed in this study. Better characterization of these
risks in patients requiring ventilation is needed.
Excluding the bicarbonate level, arterial blood gas
analysis parameters before transport were significantly
related to P-AEs or critical P-AEs during IHT in our
study. These variables have not been studied as potential
risk factors for AEs during IHT of ICU patients. Strauch
et al. [25] reported that patients who died within 24 h
after inter-hospital transport had a lower pH. Patients
with an abnormal pH and PaCO2 were more prone to
developing P-AEs during transport, and PaO2 was an
independent influential factor for critical P-AEs. Blood
lactate concentrations have been widely used as an indi-
cator of disease severity [32, 33], and elevated lactate
clearance is reportedly predictive of lower mortality in
critically ill patients [34]. A high lactate level (≥2 mmol/L)
before transport was a predictive factor for P-AEs or crit-
ical P-AEs during IHT of the patients in the present study.
Additionally, a glucose level <4 or >10 mmol/L before
transport was identified as a predictive factor for P-AEs or
critical P-AEs during IHT.
Patients with physiologic instability before transport
had a higher incidence of AEs during inter-facility trans-
port [18]. Abnormal vital signs are reported to be strongly
associated with adverse outcomes [15]. Our study found
that vital signs were associated with P-AEs during IHT;
this has not been described in previous studies. Patients
with an HR <50 or >110 had more P-AEs than those in a
safe severity category. Furthermore, RR and SpO2 were
both influential factors for critical P-AEs during IHT.
However, blood pressure was not found to be related
to the occurrence of P-AEs in our study.
The duration of transport is also reportedly associated
with AEs during transport of critically ill patients [26, 31].
IHT should be coordinated with the destination to shorten
travel time and delays as much as possible. However, our
results showed that a long IHT duration was not a signifi-
cant risk factor for P-AEs, which is the same result found
by Seymour et al. [24]. Unlike a similar study [6], emer-
gency transport was not found to significantly increase the
risk of P-AEs in our patients. Night transport and multiple
IHTs of the same patient at different times were not
risk factors for P-AEs during IHT, as previously described
Table 7 Risk factors for critical patient-related adverse events during intra-hospital transport (Continued)
DBP, mmHg 1.00 (0.98–1.01) 0.64 NT
MAP, mmHg 1.00 (0.99–1.02) 0.95 NT
Heart rate
50–110 Reference –
< 50 or >110 4.53 (2.76–7.42) 0.00* 2.97 (1.66–5.32) 0.00*
Respiratory rate
12–25 Reference –
< 12 or >25 3.06 (1.92–4.89) 0.00* 2.45 (1.39–4.33) 0.00*
Pulse oximetry 0.84 (0.78–0.91) 0.00*
≥ 95 Reference –
< 95 3.56 (1.94–6.52) 0.00* 2.79 (1.31–5.95) 0.01*
Analgesia 1.34 (0.78–2.30) 0.28 NT
Sedation 1.96 (1.25–3.09) 0.00* 1.87 (1.07–3.29) 0.03*
Vasoactive drug support 1.51 (0.96–2.37) 0.07 NT
Transport characteristics
Analgesia 0.90 (0.47–1.76) 0.76 NT
Sedation 1.27 (0.77–2.10) 0.36 NT
Vasoactive drug support 1.76 (1.10–2.83) 0.02* 1.63 (0.92–2.88) 0.10
Emergency transport 1.54 (1.33–1.89) 0.01* 1.26 (0.68–2.35) 0.47
Multiple IHTs of one patient 0.84 (0.54–1.31) 0.45 NT
Night transport 0.83 (0.37–1.87) 0.65 NT
Transport duration, minutes 0.99 (0.97–1.01) 0.18 NT
APACHE Acute Physiology and Chronic Health Evaluation, PaO2 partial pressure of oxygen in arterial blood, PaCO2 partial pressure of carbon dioxide in arterial
blood, SBP Systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, NT not tested, OR odds ratio, CI confidence interval
*P < 0.05
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[3, 6]. These transport-related factors must be further
investigated with more IHT cases.
Anxiety or agitation was recorded in more than 25 %
of transports. Pain, discomfort, and resistance to ventila-
tion when intubated occurred in about 19 % of IHTs.
These AEs were perhaps due to inadequate analgesia and
sedation in our patients. Patient sedation before transport
is a well-described risk factor for AEs during IHT [3], but
sedation was associated only with critical P-AEs in our
study. Further research on this association is needed.
Strategies to minimize AEs
Various maneuvers have been reported to improve pa-
tient IHT outcomes. Transport monitors are not rou-
tinely used during the IHT of ICU patients in China,
although recommendations for their use have been pub-
lished [35]. Transport monitoring is an essential part of
IHT. Manual ventilation of critically ill mechanically
ventilated patients can be performed safely during trans-
port [36]. However, transport ventilators provide more
reliable and stable ventilatory support than do manual
ventilators and are preferable for IHT [27]. Non-invasive
positive pressure ventilation is increasingly being used in
patients with acute respiratory failure in the ICU setting
[37]. The authors of one study reported that dedicated
non-invasive ventilators allow better patient–ventilator
synchrony than do ICU and transport ventilators [38].
Availability of a medical emergency team can also im-
prove outcomes after AEs [39]. Use of resistive heating
has been shown to be effective in maintaining the core
temperature of ICU patients during IHT [40].
Recommendations for the IHT of critically ill patients
have been published [4, 35, 41–44]. These recommenda-
tions cover pretransport coordination and communica-
tion, care of patient equipment, patient monitoring during
transport, preparation of the patient before transport,
documentation of transport, and training of caregivers
involved in the transport processes. However, hospitals
should implement policies and procedures to mitigate the
risks associated with IHT in practice [45].
Study limitations
This study has several limitations. The impact of IHT on
patient outcomes, such as the ICU or hospital length of
stay and mortality rate, was not evaluated. Risk factors
for E-AEs during IHT were not analyzed, owing to the
inadequate case numbers. Because more than 50 % of
the data for pain scales and sedation scores before or
during transport were missing, their predictive values for
AEs were not assessed in our study. Patient diagnosis,
electrolyte levels, use of neuromuscular blockade medi-
cation, use of nutritional support, fluid therapy, use of
infusion pumps, ventilator modes and settings, and accom-
panying personnel were also not evaluated as potential
influential factors for P-AEs. Finally, standardized methods
to transport patients, such as the use of transport protocols
or well-trained transport teams, may reduce the incidence
of AEs during transport. These programs used in the ICUs
that participated in our study might have been important
influential factors for AEs. However, the information was
not recorded, and further research is needed.
Conclusions
To our knowledge, this is the first prospective multicen-
ter study to comprehensively identify the incidence and
risk factors of AEs during the IHT of different ICU pa-
tients. A high P-AE rate was found in our patients. Risk
factors for P-AEs during IHT were identified. These in-
cluded abnormal pH and PaCO2, high lactate levels, and
specific glucose levels before transport. Critical P-AEs
were associated with the APACHE II score, PaO2, lactate
level, glucose level, HR, RR, SpO2, and sedation before
transport. Strategies designed to minimize AEs during
IHT are needed in practice.
Key messages
 The incidence of P-AEs during IHT of ICU patients
in this multicenter study in China was very high.
 New risk factors for P-AEs during IHT were abnormal
PH and PaCO2, high lactate levels, and specific glucose
level before transport. Critical P-AE was associated
with APACHE II score, PaO2, lactate level, glucose
level, HR, RR, SpO2, and sedation before transport.
 Strategies designed to minimize AE during IHT are
needed in practice.
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